Dr. Steven A. Carr, Director of Proteomics at the Broad Institute, will describe his laboratories leading efforts to establish a biomarker pipeline that uses MRM-MS in combination with peptide immunoaffinity enrichment (SISCAPA) to develop multiplexed assays with near clinical-grade performance for verification of candidate biomarkers in plasma.

Dr. Ruedi Aebersold, Professor of Molecular Systems Biology at ETH Zurich, will present the groundbreaking effort that is underway to systematically develop MRM’s to thousands of human and yeast proteins, and the MRMAtlas project. The goal of these efforts is to generate and make freely accessible validated MRM assays for every protein of the respective proteomes.

Dr. Christie Hunter, Director of Applications Research at Applied Biosystems/MDS Analytical Technologies, will explain the unique capabilities of the QTRAP® system technology and how it can be employed to accelerate MRM assay development and provide the multiplexing and throughput required by researchers today.

Dr. Steven A. Carr, The Broad Institute of MIT and Harvard

Dr. Ruedi Aebersold, Institute of Molecular Systems Biology, ETH Zurich

Dr. Christie Hunter, Applied Biosystems / MDS Analytical Technologies

Moderator:

Dr. Stephen R. Pennington, Conway Institute of Biomolecular and Biomedical Research at University College Dublin

 Free registration at  http://tinyurl.com/ycllx5k

Webinar can also be viewed after the event.